SecBot SecBot

340B Accountability Act of 2023

S. 1133 Sen. Mike Braun (R-IN) In committee
  1. Introduced Mar 30
  2. Committee Mar 30
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Mar 30, 2023Next: Senate vote
1308d ago Mar 30, 2023: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

340B Accountability Act of 2023

Full summary1 paragraphs

This bill requires participants in the 340B drug pricing program to allow the Health Resources & Services Administration (HRSA) to audit their records to determine how they use the net income from the discounted drug prices under the program. Participants also must retain records and reports as necessary for HRSA to perform the audits.

Library of Congress summary, Mar 30, 2023

Summary versions
  • Introduced in SenateMar 30, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.